RYR2 and catecholaminergic polymorphic ventricular tachycardia: The antiarrhythmic actions of flecainide on RyR2 channels have also been demonstrated in a cardiac calsequestrin knockout catecholaminergic polymorphic ventricular tachycardia (CPVT) mouse model [106,137] (Table 1).